Luitpold News

Adequan® i.m. Getting Ahead of Equine Degenerative Joint Disease

Written by: Betsy LaBelle

Adequan® i.m. (polysulfated glycosaminoglycan), the only product approved by the FDA for the intramuscular treatment of non-infectious degenerative and/or traumatic joint dysfunction and associated lameness of the carpal and hock joints in horses, has been a great help to the horse industry. For the past 25 years and counting, veterinarians have depended on Adequan® for the treatment of degenerative joint disease in horses.

Proper equine joint function is the precise and harmonious system of tissues that provide strength, stability and protection while allowing a broad range of movement and flexibility. When in a balanced state, healthy joints provide an efficient mechanism to restore aged cells and stimulate repair for minimal loss to the essential joint cartilage. However, this ongoing joint wear-and-repair cycle in even the healthiest of horses can become overwhelmed and insufficient when joints are overloaded from training, excessive use, athletic endeavors, weak conformation or unbalanced feet.

Read the Editorial

U.S. Reining Team to wear Adequan® Brand at 2014 World Equestrian Games

Lexington, Ky. – The United States Equestrian Federation (USEF) announced today that Luitpold Animal Health, the manufacturers of Adequan® i.m. (polysulfated glycosaminoglycan), will be the title sponsor of the 2014 U.S. Reining Team, set to compete at this year's Alltech FEI World Equestrian Games, August 23 through September 7, in Normandy, France. Luitpold Animal Health will also provide Adequan® i.m. for all eight disciplines and the horses competing for Team USA in the 2014 WEG.

Read the press release

Adequan ® i.m. (polysulfated glycosaminoglycan) Availability

Shirley, NY (May 23, 2014) - Luitpold Animal Health, a division of Luitpold Pharmaceuticals, Inc., manufacturers of Adequan® i.m. (polysulfated glycosaminoglycan), Adequan® I.A. (polysulfated glycosaminoglycan), and Adequan® Canine (polysulfated glycosaminoglycan) provides the following supply update:

Adequan i.m. is currently available in the 5 mL single dose vials only, for use in horses.

Adequan® is available only through your veterinarian. We apologize for any inconvenience caused by the disruption in our supply and are working diligently towards meeting market demand. If you are a veterinarian and need to order Adequan® or are having difficulty getting Adequan® from your veterinarian, or are a 50 mL customer, please call our Customer Service Department at (800) 458-0163 and we will assist you.

Read the press release

Adequan ® i.m. (polysulfated glycosaminoglycan) Availability

Shirley, NY (June 27, 2013) – Luitpold’s Shirley, NY manufacturing facility is undergoing renovations and upgrades to meet enhanced quality standards and address observations made by the U.S. Food and Drug Administration (FDA). This has resulted in shortages to the marketplace for the following Animal Health products: Adequan® IM, Adequan® IA, and Adequan® Canine.

Read the press release

Adequan ® i.m. (polysulfated glycosaminoglycan) Availability

Shirley, NY (May 8, 2013) – Due to renovations to our Shirley, NY factory, supplies of Adequan® i.m., the only polysulfated glycosaminoglycan (PSGAG) approved by the Food and Drug Administration (FDA), are expected to be limited over the coming months.
Read the press release

Drug or Lavage – What's the right treatment?

When a horse becomes sick or lame, you turn to your veterinarian for a diagnosis and the best, proven treatment to make your animal better.
But, just because a product is available for purchase doesn’t make it a proven product or the right product to treat the problem. So, do you treat with an FDA-approved innovator drug, an FDA-approved generic drug, a medical device or a compounded product?

Click here to download tips on choosing the right treatment.

Select Year to view Archived News

2012 FTI Consulting Winter Equestrian Festival

The 2012 FTI Consulting Winter Equestrian Festival (FTI WEF) is a popular show for professional jumpers around the world. With the world class facilities in place and the pleasant SouthFlorida weather, it’s the best place to be for aspiring and established riders alike. And this year the registrations and prize money figures have increased it’s prowess.

"This is going to be a great circuit. Our prize money is up significantly," says Equestrian Sport Productions president Michael Stone. "This is one of the biggest international horse shows, putting us up there with any European show."

Click here for a recap of 2012 WEF activities.

Equestrian Sport Productions Announces Adequan® as Title Sponsor for the Global Dressage Festival

Wellington, FL - March 30, 2012 - Equestrian Sport Productions, the management company for the Global Dressage Festival at the Palm Beach International Equestrian Center, is pleased to announce that Adequan® has signed on as the title sponsor of the Global Dressage Festival. This three-year, major sponsorship begins in 2013 and will extend through the 2015 show season.

Click here to read the full press release.

Nominations for the 2012 PATH Intl. Annual Awards are open

Do you have a talented equestrian at your PATH Intl. center? Do you admire a particular instructor or an equine specialist in mental health and learning? Does a special horse, mule or mini that has a priceless attitude call your center home?

Click here to learn about a new award and how to nominate a deserving vet.

Luitpold Pharmaceuticals receives Warning Letter from FDA

Luitpold Pharmaceuticals, Inc., is notifying the public that it received a Warning Letter from the New York District Office of the Food and Drug Administration (“FDA”) yesterday. The Warning Letter results from an inspection of Luitpold’s facilities held by FDA from February 9, 2011, through March 15, 2011.

In response to FDA’s concerns, Luitpold voluntarily suspended manufacturing operations from April 14, 2011 to May 16, 2011 during which time Luitpold focused its efforts on addressing the FDA observations, improving its processes and quality systems, and reviewing operations to ensure that it was capable of producing safe and effective drug products.
Click here to read the entire press release.

Luitpold Pharmaceuticals, Inc. Adequan Available

As of today, Luitpold Pharmaceuticals, Inc. Animal Health Division has an abundant supply of Adequan® i.m. (polysulfated glycosaminoglycan) 5ml single dose vials and 50mL multi-dose vials.
Read the full press release here.

Adequan is the Official Joint Therapy of USDF

The United States Dressage Federation (USDF) is extremely pleased to announce that Luitpold Pharmaceuticals, Inc. manufacturer of the joint therapy Adequan® (POLYSULFATED GLYCOSAMINOGLYCAN) renewed their commitment to sponsor the annual USDF National Convention and Symposium and the USDF year-end horse awards.
Read the press release here

Adequan was a proud sponsor of the 2010 AQHA World Show!

Forty-four states and 13 different countries were represented with over $2 million in awards and cash prizes given to top competitors at the 2010 AQHA World Championship show. Adequan is proud to sponsor and congratulates the contestants and winners of this year’s World Show.
Read the Story

For successful Arabian reining trainer joint health management pays off in show pen

Preventing lameness is the best policy when training performance horses that compete at a high level. Although that may not always be possible, Arabian horse reining trainer John O’Hara understands the impact of lameness. He manages his horses to maintain joint health throughout their performance careers.
Read the Story

Physical conditioning and daily care are essential for both horse and rider

Just finishing the course is a win, says Meg Sleeper, of her potential 100-mile ride in the 2010 Alltech FEI World Equestrian Games (WEG) on September 26. If the 42-year-old veterinary cardiologist from Frenchtown, New Jersey, is selected to be one of the five U.S. team riders on one of her two qualified horses, it will be the culmination of many years of training for both her and her horses.
Read the Story

Turnout, slow training and nutrition are keys to soundness

Maintaining joint health and the soundness of horses can be a challenge to owners, their farriers and their veterinarians. Whether a performance horse in training or a backyard horse for pleasure, most agree that soundness starts with good conformation and proper shoeing. But other management factors can help keep joints in healthy balance.
Read the Story

Adequan®Joins Forces With Arabian Horse Association As The "Official Joint Therapy" Sponsor

The Arabian Horse Association announced that one of the nation's leaders in the fight against degenerative joint disease in horses, the veterinarian-trusted name of Adequan® (polysulfated glycosaminoglycan) is now a corporate sponsor and the "Official Joint Therapy Sponsor of AHA."
Read the Press Release

Importance of a package insert

To assure the information you are reading is accurate and supported by research, read the package insert of the product. Any product with a package insert guarantees that you are using an effective, safe and well-documented treatment. These products are backed by the Food and Drug Administration (FDA) and have passed a stringent approval process.
Read the Story

Adequan® I.M. now available in Multi-Dose vial

Luitpold Animal Health announced that the U.S. Food and Drug Administration (FDA) has approved Adequan® i.m. Multi-Dose (polysulfated glycosaminoglycan), a new convenient 10-Dose 50mL vial. After 20 years of proven performance, Adequan® i.m. is the only FDA-approved treatment for non-infectious degenerative joint disease in horses. (Studies have not been conducted to establish safety in breeding horses. WARNING: Do not use in horses intended for human consumption.)
Read the Press Release

Adequan®becomes AQHA's Newest Corporate Partner

The New Year begins with a new partnership between Luitpold Pharmaceuticals’ Adequan® and the American Quarter Horse Association. Luitpold is the manufacturer of the well-known joint therapy product Adequan® (Polysulfated Glycosaminoglycan). Adequan® is now the official equine joint therapy of AQHA.
Read the Press Release

When soundness counts, concentrate on conformation, correct shoeing and proven joint therapy

As anyone involved in the performance horse business knows, keeping horses sound and competitive is an ongoing challenge. Trainers, veterinarians and horse owners all agree that performance relies on the sound legs of the horse athlete.
Read the Story

2010 FTI Winter Equestrian Festival and Week Four Title Sponsor Adequan® Work Together

The 2010 FTI Winter Equestrian Festival (WEF) is pleased to welcome their week four title sponsor, Adequan®. Along with their week four title sponsorship, Adequan® is the title sponsor of the $75,000 Adequan® Grand Prix, CSI 2* on Sunday, February 7, and the overall circuit sponsor of the Young Jumper divisions for Five Year Olds, Six Year Olds, and Seven/Eight Year Olds. This is the sixth year that Adequan® has sponsored at the FTI Winter Equestrian Festival.
Read the Press Release

Adequan®sponsors print coverage of Road to the Triple Crown

Leading joint medication company Adequan®i.m. (polysulfated glycosaminoglycan) will sponsor print coverage of the Road to the Triple Crown that appears in the THOROUGHBRED TIMES weekly publication and THOROUGHBRED TIMES TODAY daily electronic publication leading up to and including the Triple Crown races.
Read the press release

2009 Adequan/USEF National Junior Jumper Championships Information Now Available

Adequan®i.m. (Polysulfated Glycosaminoglycan) sponsors the annual USEF National Junior Jumper Championships which will be held October 8-10, 2009 in Harrisburg, PA.
Read the press release

Luitpold Pharmaceuticals, Inc. Launches Campaign to Provide Adequan®i.m.

(Polysulfated Glycosaminoglycan) Joint Therapy to Horses Aiming for 2008 Olympic Games
Luitpold is providing Adequan®i.m. to the horses that will represent the United States at the 2008 Olympic Games this summer, a valuable contribution to the USEF’s High Performance programs.
Read the press release

Adequan® Becomes NRCHA Corporate Partner

Luitpold is providing Adequan®i.m. to the horses that will represent the United States at the 2008 Olympic Games this summer, a valuable contribution to the USEF’s High Performance programs.
Read the press release

USDF Announces 2008 Hall of Fame Inductees

The United States Dressage Federation (USDF) will induct Robert Dover and Fiona Baan into the Roemer Foundation/USDF Hall of Fame (HOF) at the Salute Gala on December 4, 2008 during the Adequan/USDF Annual Convention in Denver, CO.
Read the press release

Revised Criteria for USDF Youth Volunteer of the Year Award

The winner of the USDF Youth Volunteer award is selected by the members of the USDF Youth Executive Board and recognized at the Adequan/USDF Annual Convention.
Read the press release

Youth Convention Scholarship

The USDF Youth Convention Scholarships award four youth participating members up to $1,000 each to help defray their costs for attending the Adequan/USDF Annual Convention. Funds for the scholarships have been raised by the USDF Youth Executive Board through a silent auction held each year at the Adequan/USDF Annual Convention.
Read the press release

USDF Welcomes New All-Breeds Participating Registries/Organizations

The United States Dressage Federation welcomes all of its new and returning Adequan/USDF all-breeds participating registries/organizations (POs).
Read the press release

Preliminary Award Standings and Archived Award Results Available Online

The United States Dressage Federation announced today that 2008 preliminary award standings for the Adequan/USDF Year-End Awards, including the Adequan/USDF All-Breeds Awards, are now available on the USDF Web site as well as archived award results for the previous two competition seasons.
Read the press release

Kyra Kyrklund Announced as 2008 Adequan/USDF National Symposium Presenter

The United States Dressage Federation is excited to announce that world-class trainer and rider, Kyra Kyrklund, is returning to conduct her third Adequan/USDF National Symposium.
Read the press release

Improved Requirements for USDF University Diploma

New criteria for the University Diploma program were approved at the 2007 Adequan/USDF Annual Convention in Orlando, FL, and take effect April 1, 2008.
Read the press release

Robert Higgins Named 2007 USDF Volunteer of the Year

United States Dressage Federation (USDF) announced the winner of the 2007 USDF Volunteer of the Year Award, presented by The Paddock Saddlery, at the 2007 Adequan/USDF Annual Convention.
Read the press release